Feedback / Questions
ORM-1153 - Orum Therap
https://www.businesswire.com/news/home/20251208836029/en/Orum-Therapeutics-Presents-Preclinical-Data-at-ASH-2025-Demonstrating-Potent-and-Selective-Antitumor-Activity-of-ORM-1153-a-CD123-Targeting-Degrader-Antibody-Conjugate-for-Acute-Myeloid-Leukemia
Dec 8, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next